Eric A MD Rose's Net Worth

$15.8 Million

Estimate Recalculated Nov 1, 2024 11:09AM EST

Who is Eric A MD Rose

Eric A MD Rose has an estimated net worth of $15.8 Million. This is based on reported shares across multiple companies, which include ABIOMED INC, NEPHROS INC, Orchestra BioMed Holdings, Inc., SIGA TECHNOLOGIES INC, and KERYX BIOPHARMACEUTICALS INC.

SEC CIK

Eric A MD Rose's CIK is 0001139301

Past Insider Trading and Trends

2015 was Eric A MD Rose's most active year for acquiring shares with 17 total transactions. Eric A MD Rose's most active month to acquire stocks was the month of May. 2015 was Eric A MD Rose's most active year for disposing of shares, totalling 19 transactions. Eric A MD Rose's most active month to dispose stocks was the month of May. 2017 saw Eric A MD Rose paying a total of $2,330,885.76 for 200,756 shares, this is the most they've acquired in one year. In 2018 Eric A MD Rose cashed out on 940,173 shares for a total of $2,457,253.26, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ABIOMED INC

Investor
Updated Aug 12, 2022
Form 4
2.48%
368.00
$293.34
-$91.82K
Aug 12, 2022
15.20K
Grant
Aug 10 - Aug 11
Form 4
2.49%
360.00
$319.88
-$84.77K
Aug 13, 2021
14.84K
Grant
Aug 11 - Aug 12
Form 4
4.79%
661.00
Aug 14, 2020
14.48K
Grant
Aug 12
Form 4
-2.96%
-422.00
$314.98
-$132.92K
Aug 11, 2020
13.81K
Tax
Aug 07
Form 4
7.99%
1.05K
Aug 09, 2019
14.24K
Grant
Aug 07
Form 4
4.20%
531.00
Aug 10, 2018
13.18K
Grant
Aug 08
Form 4
-7.20%
-982.00
$76.42
-$135.02K
Sep 01, 2017
12.65K
Sale
Aug 30
Form 4
-2.66%
-976.00
$104.39
$170.59K
Aug 28, 2017
13.63K
Sale
Aug 24
Form 4
-8.90%
-1.22K
$151.37
-$184.97K
Aug 15, 2017
36.51K
Tax
Aug 13
Form 4
3.60%
477.00
$155.87
-$125.63K
Aug 11, 2017
37.74K
Grant
Aug 09
Form 4
-37.63%
-8.00K
$61.75
-$784.95K
Dec 02, 2016
37.26K
Sale
ScheduledNov 30
Form 4
13.93%
1.62K
Aug 11, 2016
45.26K
Grant
Aug 09
Form 4
50.39%
3.90K
Aug 14, 2015
43.64K
Grant
Aug 12
Form 4
-65.96%
-15.00K
$31.35
-$602.48K
Feb 04, 2015
39.74K
Sale
Feb 02
Form 4
7.74K
Aug 21, 2014
54.74K
Grant
Aug 13
Form 3
Aug 21, 2014
Form 4
5.33K
Aug 12, 2011
74.33K
Grant
Aug 10
Form 4
12.00K
Aug 13, 2010
69.00K
Grant
Aug 11
Form 4
-50.00%
-12.00K
$7.67
-$92.04K
Aug 14, 2009
57.00K
Grant
Aug 12
Form 4
12.00K
$18.63
$223.56K
Aug 15, 2008
45.00K
Grant
Aug 13
Form 4
8.00K
$12.69
$101.52K
Aug 10, 2007
33.00K
Grant
Aug 08
Form 4
25.00K
$11.27
$281.75K
Jun 01, 2007
25.00K
Grant
May 30
Form 3
Jun 01, 2007
Showing 23 results

NEPHROS INC

Investor
Updated Jun 16, 2009
Form 4
-26.19%
-195.15K
$1.36
-$265.25K
Jun 16, 2009
550.00K
Sale
Jun 10 - Jun 15
Form 4
10.00K
May 24, 2007
10.00K
Grant
May 22
Form 4
10.00K
Feb 06, 2006
10.00K
Grant
Feb 02
Form 4
10.00K
Apr 29, 2005
10.00K
Grant
Apr 27
Form 4
-36.56%
-429.39K
Sep 27, 2004
745.15K
Options
Sep 24
Form 3
Sep 24, 2004
499.54K
Showing 6 results

Orchestra BioMed Holdings, Inc.

Investor
Updated Jun 21, 2024
Form 4
1,035.24%
22.44K
Jun 21, 2024
24.61K
Grant
Jun 20
Form 4
25.00K
Jul 24, 2023
25.00K
Grant
Jul 20
Form 4
-3.38%
-157.00
$8.56
-$7.28
May 19, 2023
4.49K
Options
May 17
Form 4/A
23.25K
May 19, 2023
23.25K
Grant
Jan 26
Form 4
54.64K
Jan 30, 2023
54.64K
Grant
Jan 26
Form 3
Jan 30, 2023
Showing 6 results

SIGA TECHNOLOGIES INC

Executive Chairman
Updated Jun 17, 2021
Form 4
Jun 17, 2021
1.07M
Options
Jun 15
Form 4
15.00K
Jun 18, 2020
15.00K
Grant
Jun 16
Form 4
May 22, 2020
1.05M
Options
May 21
Form 4
-4.99%
-54.50K
$4.92
-$268.14K
Nov 26, 2019
1.04M
Options
Nov 22
Form 4
15.00K
May 22, 2019
15.00K
Grant
May 21
Form 4
-8.83%
-105.90K
$5.55
-$587.72K
Nov 26, 2018
1.09M
Options
Nov 22
Form 4
-20.67%
-234.28K
$5.24
-$873.53K
Aug 22, 2018
898.99K
Options
Aug 20
Form 4
-36.23%
-416.66K
$4.00
$124.16K
Nov 17, 2017
733.27K
Options
Nov 13
Form 4
-4.13%
-29.50K
$2.93
-$86.44K
Jan 05, 2017
684.93K
Options
Jan 03
Form 4
-10.54%
-68.47K
$3.13
-$214.31K
Dec 12, 2016
714.43K
Options
Dec 08
Form 4
300.00K
Nov 23, 2016
300.00K
Grant
Nov 22
Form 4
-2.49%
-20.00K
$1.21
-$24.20K
Sep 24, 2015
782.90K
Sale
Sep 22 - Sep 24
Form 4
-2.43%
-20.00K
$1.32
-$26.40K
Sep 03, 2015
802.90K
Sale
Sep 01 - Sep 02
Form 4
10.03%
75.00K
$1.43
-$35.79K
Jun 24, 2015
822.90K
Sell-Options
Jun 22 - Jun 24
Form 4
Jun 09, 2015
847.90K
Options
Jun 08
Form 4
-5.29%
-25.00K
$1.67
-$41.64K
Jun 04, 2015
447.90K
Sale
Jun 02 - Jun 04
Form 4
-4.85%
-27.49K
$3.21
-$88.24K
Mar 04, 2014
552.87K
Options
Feb 28
Form 4
28.06%
170.97K
$3.35
-$97.26K
Jan 07, 2014
780.35K
Purchase
Jan 03
Form 4
-4.91%
-27.31K
$4.28
-$116.90K
Mar 04, 2013
542.62K
Options
Feb 28
Form 4
200.00K
Jan 07, 2013
200.00K
Grant
Jan 03
Form 4
200.00K
Mar 01, 2012
200.00K
Grant
Feb 28
Form 4
465.00K
Feb 03, 2012
465.00K
Grant
Feb 02
Form 4
-25.75%
-123.67K
$2.10
-$259.70K
Dec 02, 2011
369.94K
Tax
Nov 30
Form 4
-14.56%
-81.88K
$13.36
-$1.09M
May 26, 2011
493.60K
Tax
May 25
Form 4
-6.87%
-41.50K
$13.65
-$566.47K
May 20, 2011
575.48K
Sale
May 19
Form 4
431.03%
490.00K
May 19, 2011
616.98K
Grant
May 17
Form 4
0.26%
7.10K
$6.00
$42.60K
Dec 15, 2009
2.69M
Purchase
Dec 15
Form 4
0.69%
18.40K
$3.06
$56.30K
Dec 17, 2008
2.67M
Purchase
Dec 15
Form 4
64.52%
400.00K
Nov 17, 2008
1.02M
Grant
Nov 14
Form 4
27.83%
200.00K
Jul 30, 2007
918.61K
Grant
Jul 26
Form 4
1.43%
10.00K
Jan 11, 2007
708.61K
Grant
Dec 19
Form 4
1.45%
10.00K
Jun 06, 2005
698.61K
Grant
Jun 02
Showing 32 results

KERYX BIOPHARMACEUTICALS INC

Investor
Updated Nov 18, 2008
Form 4
155.00K
Nov 18, 2008
155.00K
Grant
Nov 14
Form 4
10.00K
Jun 20, 2008
10.00K
Grant
Jun 18
Form 4
40.00K
Jun 22, 2007
40.00K
Grant
Jun 21
Form 4
10.00K
Jun 09, 2006
10.00K
Grant
Jun 09
Form 4
-5.00%
-5.00K
$14.97
-$31.41K
Mar 16, 2006
95.00K
Sale
Mar 14
Form 4
10.00K
Jun 10, 2005
10.00K
Grant
Jun 09
Form 3
Sep 29, 2004
Showing 7 results